I-Evotaz (atazanavir + cobicistat) - Ulwazi lwe-HIV lweDrug

Ukuhlukaniswa

I-Evotaz (atazanavir + cobicistat) iyinani elinqunyiwe elihlanganiswa nomuthi we- antiretroviral esetshenziswa ekwelapheni i- HIV . Izingxenye ezimbili zomuthi zidayiswa njengeReyataz (atazanavir) noTybost (cobicistat) .

Ukuhlanganiswa kwe-single-pilules kuvumela ukulula okulula, kanye-kwansuku zonke, kanye ne-cobicistat component ngokuphumelelayo "ukukhuthaza" nokugcina ukuhlushwa kwe-plasma ye-atazanavir emzimbeni.

U-Evotaz wamukelwa yi-US Food and Drug Administration (FDA) ngoJanuwari 2015 kubo bonke abagulayo abasha nabahlangenwe nakho abane-HIV-1.

Ifomu

Ithebhulethi ene-oblong egcwele ifilimu, enama-300mg atazanavir no-150mg cobicistat, i-pink inemibala futhi ifakwe izinombolo "3641" ngakolunye uhlangothi.

Isilinganiso

Ithebhulethi eyodwa ithathwa nsuku zonke ngokudla. I-Evotaz ayikwazi ukusetshenziselwa yedwa kodwa kufanele ithathwe ngokuhambisana nomuthi owodwa noma ngaphezulu ohambisana nezidambisigciwane.

Imiyalo

Ngaphambi kokuqala, iziguli kufanele zihlolwe ukuze zihlolwe imvume yabo yokuqalwa kwama-creatinine njengoba i-Evotaz ingase ibangele ukusebenza kwe-renal (izinso), ikakhulukazi ezigulini ezinezifo ezingasebenzi ezingaziwa noma ezingaziwa. Uma uqondiswa nge- Viread (i-tenofovir ) -isidakamizwa esingabangela ukukhubazeka kwamaphutha kwezinye-kunconywa ukuthi iziguli zivivinywe imvume yokucatshangelwa kwe-creatinine, i-glucose yomchamo, kanye ne-protein yomchamo.

Kunconywa ukuthi iziguli ezinolwazi lwezokwelashwa, ikakhulukazi lezo ezivezwe nge-HIV protease inhibitors , zihlinzekwa ukuhlolwa kokuphikiswa kwezakhi zofuzo ngaphambi kokuba kubekwe u-Evotaz.

Uma ukuhlolwa kwe-genotypic kungatholakali, u-Evotaz kufanele agwenywe kunoma ubani ovezwe ngaphambilini kwi-HIV protease inhibitors.

Imiphumela Ejwayelekile Ejwayelekile

Esifundweni sesifundo se-Phase III somuntu, kunezibalo eziningana zomuthi wezokwelapha eziye zabonakala uma usebenzisa u-Evotaz. Izenzakalo ezivame kakhulu, ezibikwe ngo-2% noma ngaphansi kweziguli ezisanda kuphulukiswa, zazi:

Imiphumela emibi engavamile ihlanganisa ukukhathala, ikhanda, ukulala, ukuhlanza kanye nobuhlungu obuphezulu besisu. Amatshe aso aphinde ahlonishwa kwezinye iziguli lapho uVevotz ephathwa nge-Viread (tenofovir), nakuba amacala ayebhekwa njengobumnene futhi awazange akhiphe ukuyeka ukukhipha ukwelashwa.

Ukuphikisana kwezidakamizwa

I-Evotaz akufanele ithathwe ngezidakamizwa ezilandelayo noma izithako ze-herbal:

Ukusebenzisana kwezidakamizwa ze-antiretroviral

Ukusetshenziswa kukaTybost ngokulandela izidakamizwa ze-antiretroviral kungaholela ekulahlekelweni komphumela wokwelashwa kwesidakamizwa esihambisana nalokhu noma ukwanda kwemiphumela emibi:

Okunye ukusebenzisana noma ukucabangela

Imithombo:

I-Bristol-Myers Squibb. "I-Evotaz (Atazanvir + cobicistat) - ULWAZI LOKUPHILA OKUQHELEKILE." ENew York, eNew York; ifinyelelwe ngoFebhuwari 3, 2015.